• HeartBeam completed patient enrollment in its ALIGN-ACS pilot study of the HeartBeam System for heart attack detection, ahead of its prior Q3 2026 target.
• Data analysis is underway; full results will be presented later this year, with a cardiology conference presentation planned in the coming months.
• The study is designed to show whether the system can support physician assessment of suspected heart attacks outside traditional clinical settings.
• Findings are expected to guide a planned US pivotal study and support FDA discussions on expanding the device’s indication beyond arrhythmia assessment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartbeam Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260630151674) on June 30, 2026, and is solely responsible for the information contained therein.